Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effect of chenodeoxycholic and ursodeoxycholic acids on isolated adult human hepatocytes.

Literature DB >> 6499631

Effect of chenodeoxycholic and ursodeoxycholic acids on isolated adult human hepatocytes.

Abstract

Chenodeoxycholic and ursodeoxycholic are effective cholelitholytic agents, but differ in their side effects. Chenodeoxycholic acid administration induces diarrhea and a transient rise of GOT, which are virtually nonexistent with ursodeoxycholic acid treatment. Lithocholic acid, a bacterial metabolite of chenodeoxycholic acid, has been implicated as a possible hepatotoxin. In the present investigation, the effect of chenodeoxycholic acid or ursodeoxycholic acid and their glycine and taurine conjugates on isolated human hypatocytes was directly assessed. Chenodeoxycholic acid had drastic effects on isolated human hepatocytes by reducing the number of microvilli and disrupting cell membranes. Pronounced release of GOT was observed. In contrast, ursodeoxycholic acid produced only slight morphological changes and enzyme release. Conjugation of each respective bile acids had a moderating effect.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1984 PMID： 6499631 DOI： 10.1007/bf01317087

Source DB: PubMed Journal: Dig Dis Sci ISSN： 0163-2116 Impact factor: 3.199

19 in total

Review 1. The enterohepatic circulation of bile acids in man.

Authors: A F Hofmann
Journal: Clin Gastroenterol Date: 1977-01

2. Isolation and primary culture of adult human hepatocytes. Ultrastructural and functional studies.

Authors: K Miyazaki; R Takaki; F Nakayama; S Yamauchi; A Koga; S Todo
Journal: Cell Tissue Res Date: 1981 Impact factor: 5.249

3. A simple method for the cultivation of rat liver cells.

Authors: T Takaoka; S Yasumoto; H Katsuta
Journal: Jpn J Exp Med Date: 1975-10

4. Transformation of chenodeoxycholic acid and ursodeoxycholic acid by human intestinal bacteria.

Authors: T Fedorowski; G Salen; G S Tint; E Mosbach
Journal: Gastroenterology Date: 1979-11 Impact factor: 22.682

5. A prospective morphologic evaluation of hepatic toxicity of chenodeoxycholic acid in patients with cholelithiasis: the National Cooperative Gallstone Study.

Authors: R L Fisher; D W Anderson; J L Boyer; K Ishak; G Klatskin; J M Lachin; M J Phillips
Journal: Hepatology Date: 1982 Mar-Apr Impact factor: 17.425

6. Hepatic uptake of bile acids in man. Fasting and postprandial concentrations of individual bile acids in portal venous and systemic blood serum.

Authors: B Angelin; I Björkhem; K Einarsson; S Ewerth
Journal: J Clin Invest Date: 1982-10 Impact factor: 14.808

7. Effects of biliary bile acid composition on biliary cholesterol saturation in gallstone patients treated with chenodeoxycholic acid and/or ursodeoxycholic acid.

Authors: A Stiehl; R Raedsch; P Czygan; R Götz; C Männer; S Walker; B Kommerell
Journal: Gastroenterology Date: 1980-12 Impact factor: 22.682

8. Comparative formation of lithocholic acid from chenodeoxycholic and ursodeoxycholic acids in the colon.

Authors: F Bazzoli; H Fromm; R P Sarva; R F Sembrat; S Ceryak
Journal: Gastroenterology Date: 1982-10 Impact factor: 22.682

9. Ultrastructural evidence of intrahepatic cholestasis before and after chenodeoxycholic acid therapy in patients with cholelithiasis: the national cooperative gallstone study.

Authors: M J Phillips; R L Fisher; D W Anderson; S P Lan; J M Lachin; J L Boyer
Journal: Hepatology Date: 1983 Mar-Apr Impact factor: 17.425

10. Light and electron microscopy of human liver before and during chenodeoxycholic acid therapy.

Authors: W Hartmann; K Paulini; H Goebell
Journal: Hepatogastroenterology Date: 1980-04

14 in total

1. Ursodeoxycholic acid therapy in chronic active hepatitis.

Authors: M C Bateson
Journal: Postgrad Med J Date: 1990-09 Impact factor: 2.401

2. New directions in primary biliary cirrhosis.

Authors: M C Bateson
Journal: BMJ Date: 1990-12-08

Review 3. [Ursodeoxycholic acid--a new therapy concept in cholestatic liver diseases].

Authors: R Raedsch; A Stiehl
Journal: Klin Wochenschr Date: 1989-02-15

4. The effectual level of ursodeoxycholic acid in therapy for non-advanced chronic cholestasis is fifty percent of total serum bile acids.

Authors: T Higuchi; N Hishida; T Isomura; H Takeshima; H Hayashi
Journal: Gastroenterol Jpn Date: 1992-04

Review 5. An updated review on drug-induced cholestasis: mechanisms and investigation of physicochemical properties and pharmacokinetic parameters.

Authors: Kyunghee Yang; Kathleen Köck; Alexander Sedykh; Alexander Tropsha; Kim L R Brouwer
Journal: J Pharm Sci Date: 2013-05-07 Impact factor: 3.534

6. Effects of ursodeoxycholic acid (UDCA) on serum liver damage indices in patients with chronic active hepatitis. A double-blind controlled study.

Authors: E Rolandi; R Franceschini; A Cataldi; V Cicchetti; L Carati; T Barreca
Journal: Eur J Clin Pharmacol Date: 1991 Impact factor: 2.953

7. Role of primary and secondary bile acids as feedback inhibitors of bile acid synthesis in the rat in vivo.

Authors: E F Stange; J Scheibner; H Ditschuneit
Journal: J Clin Invest Date: 1989-07 Impact factor: 14.808

8. Differential disposition of chenodeoxycholic acid versus taurocholic acid in response to acute troglitazone exposure in rat hepatocytes.

Authors: Tracy L Marion; Cassandra H Perry; Robert L St Claire; Wei Yue; Kim L R Brouwer
Journal: Toxicol Sci Date: 2011-01-24 Impact factor: 4.849

9. Effects of ursodeoxycholic acid treatment on nutrition and liver function in patients with cystic fibrosis and longstanding cholestasis.

Authors: J Cotting; M J Lentze; J Reichen
Journal: Gut Date: 1990-08 Impact factor: 23.059

10. Glycochenodeoxycholate-induced lethal hepatocellular injury in rat hepatocytes. Role of ATP depletion and cytosolic free calcium.

Authors: J R Spivey; S F Bronk; G J Gores
Journal: J Clin Invest Date: 1993-07 Impact factor: 14.808